View Future GrowthPhosAgro 過去の業績過去 基準チェック /56PhosAgroは、平均年間43.8%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 成長しています。収益は、平均年間0.2% 20.6%収益成長率で 成長しています。 PhosAgroの自己資本利益率は73.8%であり、純利益率は36.2%です。主要情報43.85%収益成長率43.85%EPS成長率Chemicals 業界の成長31.77%収益成長率20.59%株主資本利益率73.83%ネット・マージン36.17%前回の決算情報30 Jun 2022最近の業績更新お知らせ • Nov 07Public Joint-Stock Company PhosAgro to Report Nine Months, 2024 Results on Nov 07, 2024Public Joint-Stock Company PhosAgro announced that they will report nine months, 2024 results on Nov 07, 2024お知らせ • May 26Public Joint-Stock Company PhosAgro to Report Q1, 2024 Results on May 27, 2024Public Joint-Stock Company PhosAgro announced that they will report Q1, 2024 results on May 27, 2024お知らせ • Apr 21Public Joint-Stock Company PhosAgro to Report Q4, 2023 Results on Apr 26, 2024Public Joint-Stock Company PhosAgro announced that they will report Q4, 2023 results on Apr 26, 2024Reported Earnings • Feb 12Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: ₽1,002 (up from ₽131 in FY 2020). Revenue: ₽420.5b (up 66% from FY 2020). Net income: ₽129.7b (up ₽112.8b from FY 2020). Profit margin: 31% (up from 6.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) also surpassed analyst estimates by 6.2%. Over the next year, revenue is forecast to grow 3.2%, compared to a 15% growth forecast for the industry in Russia. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 12Third quarter 2021 earnings released: EPS ₽303 (vs ₽10.19 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₽116.3b (up 64% from 3Q 2020). Net income: ₽39.2b (up ₽40.5b from 3Q 2020). Profit margin: 34% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year whereas the company’s share price has increased by 32% per year.Reported Earnings • Aug 08Second quarter 2021 earnings released: EPS ₽234 (vs ₽161 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₽88.7b (up 48% from 2Q 2020). Net income: ₽30.3b (up 45% from 2Q 2020). Profit margin: 34% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.すべての更新を表示Recent updatesお知らせ • Mar 21Public Joint-Stock Company PhosAgro, Annual General Meeting, May 29, 2025Public Joint-Stock Company PhosAgro, Annual General Meeting, May 29, 2025. Location: leninsky prospect 55 1, moscow Russiaお知らせ • Feb 17Public Joint-Stock Company PhosAgro, Annual General Meeting, Apr 09, 2025Public Joint-Stock Company PhosAgro, Annual General Meeting, Apr 09, 2025.お知らせ • Nov 07Public Joint-Stock Company PhosAgro to Report Nine Months, 2024 Results on Nov 07, 2024Public Joint-Stock Company PhosAgro announced that they will report nine months, 2024 results on Nov 07, 2024お知らせ • May 31Public Joint-Stock Company PhosAgro, Annual General Meeting, Jun 30, 2024Public Joint-Stock Company PhosAgro, Annual General Meeting, Jun 30, 2024.お知らせ • May 26Public Joint-Stock Company PhosAgro to Report Q1, 2024 Results on May 27, 2024Public Joint-Stock Company PhosAgro announced that they will report Q1, 2024 results on May 27, 2024お知らせ • Apr 21Public Joint-Stock Company PhosAgro to Report Q4, 2023 Results on Apr 26, 2024Public Joint-Stock Company PhosAgro announced that they will report Q4, 2023 results on Apr 26, 2024お知らせ • Feb 23PhosAgro Global Depositary Receipts - Sponsored to be Deleted from OTC EquityPublic Joint-Stock Company PhosAgro Global Depositary Receipts - Sponsored will be deleted from OTC Equity effective February 22, 2024, due to CUSIP Suspended.Upcoming Dividend • Jul 01Upcoming dividend of ₽390 per shareEligible shareholders must have bought the stock before 08 July 2022. Payment date: 12 July 2022. Payout ratio and cash payout ratio are on the higher end at 88% and 94% respectively. Trailing yield: 11%. Lower than top quartile of Russian dividend payers (12%). Higher than average of industry peers (7.7%).Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 2 highly experienced directors. Independent Director Natalia Pashkevich was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 2 highly experienced directors. Independent Director Natalia Pashkevich was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Major Estimate Revision • Feb 26Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast fell from ₽521.8b to ₽497.2b. EPS estimate rose from ₽1,261 to ₽1,831. Net income forecast to grow 66% next year vs 15% growth forecast for Chemicals industry in Russian Federation. Consensus price target down from ₽6,057 to ₽5,501. Share price fell 12% to ₽5,145 over the past week.Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorated over the past weekAfter last week's 26% share price decline to ₽4,378, the stock trades at a forward P/E ratio of 2x. Average forward P/E is 15x in the Chemicals industry in Europe. Total returns to shareholders of 128% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₽5,452 per share.Major Estimate Revision • Feb 19Consensus EPS estimates increase by 45%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from ₽488.8b to ₽527.6b. EPS estimate increased from ₽1,261 to ₽1,831 per share. Net income forecast to shrink 12% next year vs 14% growth forecast for Chemicals industry in Russian Federation . Consensus price target broadly unchanged at ₽5,597. Share price was steady at ₽5,870 over the past week.Major Estimate Revision • Feb 17Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽416.5b to ₽477.2b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price was steady at ₽5,926 over the past week.Reported Earnings • Feb 12Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: ₽1,002 (up from ₽131 in FY 2020). Revenue: ₽420.5b (up 66% from FY 2020). Net income: ₽129.7b (up ₽112.8b from FY 2020). Profit margin: 31% (up from 6.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) also surpassed analyst estimates by 6.2%. Over the next year, revenue is forecast to grow 3.2%, compared to a 15% growth forecast for the industry in Russia. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.Major Estimate Revision • Feb 11Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽409.3b to ₽473.3b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price rose 13% to ₽5,936 over the past week.Upcoming Dividend • Dec 10Upcoming dividend of ₽234 per shareEligible shareholders must have bought the stock before 17 December 2021. Payment date: 21 December 2021. Payout ratio is a comfortable 72% and this is well supported by cash flows. Trailing yield: 5.3%. Lower than top quartile of Russian dividend payers (8.2%). Higher than average of industry peers (4.0%).Reported Earnings • Nov 12Third quarter 2021 earnings released: EPS ₽303 (vs ₽10.19 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₽116.3b (up 64% from 3Q 2020). Net income: ₽39.2b (up ₽40.5b from 3Q 2020). Profit margin: 34% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year whereas the company’s share price has increased by 32% per year.Upcoming Dividend • Sep 16Upcoming dividend of ₽156 per shareEligible shareholders must have bought the stock before 23 September 2021. Payment date: 27 September 2021. Trailing yield: 5.9%. Lower than top quartile of Russian dividend payers (8.1%). Higher than average of industry peers (2.4%).Reported Earnings • Aug 08Second quarter 2021 earnings released: EPS ₽234 (vs ₽161 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₽88.7b (up 48% from 2Q 2020). Net income: ₽30.3b (up 45% from 2Q 2020). Profit margin: 34% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.Major Estimate Revision • Aug 07Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 revenue forecast increased from ₽325.4b to ₽393.0b. EPS estimate unchanged from ₽524 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 17% next year. Consensus price target broadly unchanged at ₽4,045. Share price was steady at ₽4,573 over the past week.Upcoming Dividend • Jun 25Upcoming dividend of ₽105 per shareEligible shareholders must have bought the stock before 02 July 2021. Payment date: 06 July 2021. Trailing yield: 6.2%. Lower than top quartile of Russian dividend payers (7.7%). Higher than average of industry peers (4.1%).Upcoming Dividend • May 28Upcoming dividend of ₽63.00 per shareEligible shareholders must have bought the stock before 04 June 2021. Payment date: 08 June 2021. Trailing yield: 6.4%. Lower than top quartile of Russian dividend payers (8.0%). Higher than average of industry peers (4.3%).Reported Earnings • May 21First quarter 2021 earnings released: EPS ₽142 (vs ₽120 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₽87.6b (up 37% from 1Q 2020). Net income: ₽18.4b (up ₽33.9b from 1Q 2020). Profit margin: 21% (up from net loss in 1Q 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Feb 20Full year 2020 earnings released: EPS ₽131 (vs ₽381 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ₽253.9b (up 2.3% from FY 2019). Net income: ₽16.9b (down 66% from FY 2019). Profit margin: 6.7% (down from 20% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.Analyst Estimate Surprise Post Earnings • Feb 20Revenue and earnings miss expectationsRevenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 11%. Over the next year, revenue is forecast to grow 13%, compared to a 3.2% growth forecast for the Chemicals industry in Russia.Is New 90 Day High Low • Feb 15New 90-day high: ₽3,717The company is up 21% from its price of ₽3,084 on 17 November 2020. The Russian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽2,498 per share.Major Estimate Revision • Feb 10Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ₽215 to ₽258. Revenue estimate for the same period was approximately flat at ₽260.9b. Net income is expected to grow by 356% next year compared to 25% growth forecast for the Chemicals industry in Russian Federation. The consensus price target was lowered from ₽50.69 to ₽47.62. Share price is down by 1.1% to ₽3,622 over the past week.Major Estimate Revision • Nov 08Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ₽226 to ₽249. Revenue estimate for the same period was approximately flat at ₽255.7b. Net income is expected to grow by 73% next year compared to 13% growth forecast for the Chemicals industry in Russian Federation. The consensus price target was lowered from ₽43.38 to ₽43.27. Share price is up 5.5% to ₽2,974 over the past week.Is New 90 Day High Low • Nov 07New 90-day high: ₽2,974The company is up 11% from its price of ₽2,680 on 07 August 2020. The Russian market is down 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽3,489 per share.Is New 90 Day High Low • Sep 28New 90-day high: ₽2,821The company is up 7.0% from its price of ₽2,643 on 30 June 2020. The Russian market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽2,189 per share.収支内訳PhosAgro の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史MISX:PHOR 収益、費用、利益 ( )RUB Millions日付収益収益G+A経費研究開発費30 Jun 22580,736210,07443,151031 Mar 22501,164175,86635,631031 Dec 21420,488129,69727,893030 Sep 21351,455100,82558,457030 Jun 21306,14460,31525,453031 Mar 21277,40050,87256,154031 Dec 20253,87916,93224,101030 Sep 20248,13010,64331,812030 Jun 20241,68821,70638,797031 Mar 20239,89612,61045,425031 Dec 19248,12549,34952,699030 Sep 19254,53447,16351,557030 Jun 19252,66845,18850,311031 Mar 19250,97736,35949,895031 Dec 18233,31222,06947,768030 Sep 18219,53921,83145,680030 Jun 18203,30721,40743,003031 Mar 18191,57519,93540,397031 Dec 17181,35125,33338,355030 Sep 17175,70832,44736,930030 Jun 17174,81437,50935,138031 Mar 17176,06749,52034,338031 Dec 16187,74259,88433,367030 Sep 16195,03953,40232,305030 Jun 16198,54944,86032,371031 Mar 16195,77944,90531,016031 Dec 15189,73236,44229,9350質の高い収益: PHOR 非現金収入 のレベルが高いです。利益率の向上: PHORの現在の純利益率 (36.2%)は、昨年(19.7%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: PHORの収益は過去 5 年間で年間43.8%増加しました。成長の加速: PHORの過去 1 年間の収益成長率 ( 248.3% ) は、5 年間の平均 ( 年間43.8%を上回っています。収益対業界: PHORの過去 1 年間の収益成長率 ( 248.3% ) はChemicals業界-1.3%を上回りました。株主資本利益率高いROE: PHORの 自己資本利益率 ( 73.8% ) は 傑出している と考えられます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2022/10/05 14:58終値2022/07/08 00:00収益2022/06/30年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Public Joint-Stock Company PhosAgro 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。10 アナリスト機関Edwin CheeBMO Capital Markets Equity ResearchJoel JacksonBMO Capital Markets Equity ResearchSashank LankaBofA Global Research7 その他のアナリストを表示
お知らせ • Nov 07Public Joint-Stock Company PhosAgro to Report Nine Months, 2024 Results on Nov 07, 2024Public Joint-Stock Company PhosAgro announced that they will report nine months, 2024 results on Nov 07, 2024
お知らせ • May 26Public Joint-Stock Company PhosAgro to Report Q1, 2024 Results on May 27, 2024Public Joint-Stock Company PhosAgro announced that they will report Q1, 2024 results on May 27, 2024
お知らせ • Apr 21Public Joint-Stock Company PhosAgro to Report Q4, 2023 Results on Apr 26, 2024Public Joint-Stock Company PhosAgro announced that they will report Q4, 2023 results on Apr 26, 2024
Reported Earnings • Feb 12Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: ₽1,002 (up from ₽131 in FY 2020). Revenue: ₽420.5b (up 66% from FY 2020). Net income: ₽129.7b (up ₽112.8b from FY 2020). Profit margin: 31% (up from 6.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) also surpassed analyst estimates by 6.2%. Over the next year, revenue is forecast to grow 3.2%, compared to a 15% growth forecast for the industry in Russia. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 12Third quarter 2021 earnings released: EPS ₽303 (vs ₽10.19 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₽116.3b (up 64% from 3Q 2020). Net income: ₽39.2b (up ₽40.5b from 3Q 2020). Profit margin: 34% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year whereas the company’s share price has increased by 32% per year.
Reported Earnings • Aug 08Second quarter 2021 earnings released: EPS ₽234 (vs ₽161 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₽88.7b (up 48% from 2Q 2020). Net income: ₽30.3b (up 45% from 2Q 2020). Profit margin: 34% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Mar 21Public Joint-Stock Company PhosAgro, Annual General Meeting, May 29, 2025Public Joint-Stock Company PhosAgro, Annual General Meeting, May 29, 2025. Location: leninsky prospect 55 1, moscow Russia
お知らせ • Feb 17Public Joint-Stock Company PhosAgro, Annual General Meeting, Apr 09, 2025Public Joint-Stock Company PhosAgro, Annual General Meeting, Apr 09, 2025.
お知らせ • Nov 07Public Joint-Stock Company PhosAgro to Report Nine Months, 2024 Results on Nov 07, 2024Public Joint-Stock Company PhosAgro announced that they will report nine months, 2024 results on Nov 07, 2024
お知らせ • May 31Public Joint-Stock Company PhosAgro, Annual General Meeting, Jun 30, 2024Public Joint-Stock Company PhosAgro, Annual General Meeting, Jun 30, 2024.
お知らせ • May 26Public Joint-Stock Company PhosAgro to Report Q1, 2024 Results on May 27, 2024Public Joint-Stock Company PhosAgro announced that they will report Q1, 2024 results on May 27, 2024
お知らせ • Apr 21Public Joint-Stock Company PhosAgro to Report Q4, 2023 Results on Apr 26, 2024Public Joint-Stock Company PhosAgro announced that they will report Q4, 2023 results on Apr 26, 2024
お知らせ • Feb 23PhosAgro Global Depositary Receipts - Sponsored to be Deleted from OTC EquityPublic Joint-Stock Company PhosAgro Global Depositary Receipts - Sponsored will be deleted from OTC Equity effective February 22, 2024, due to CUSIP Suspended.
Upcoming Dividend • Jul 01Upcoming dividend of ₽390 per shareEligible shareholders must have bought the stock before 08 July 2022. Payment date: 12 July 2022. Payout ratio and cash payout ratio are on the higher end at 88% and 94% respectively. Trailing yield: 11%. Lower than top quartile of Russian dividend payers (12%). Higher than average of industry peers (7.7%).
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 2 highly experienced directors. Independent Director Natalia Pashkevich was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 2 highly experienced directors. Independent Director Natalia Pashkevich was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Major Estimate Revision • Feb 26Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast fell from ₽521.8b to ₽497.2b. EPS estimate rose from ₽1,261 to ₽1,831. Net income forecast to grow 66% next year vs 15% growth forecast for Chemicals industry in Russian Federation. Consensus price target down from ₽6,057 to ₽5,501. Share price fell 12% to ₽5,145 over the past week.
Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorated over the past weekAfter last week's 26% share price decline to ₽4,378, the stock trades at a forward P/E ratio of 2x. Average forward P/E is 15x in the Chemicals industry in Europe. Total returns to shareholders of 128% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₽5,452 per share.
Major Estimate Revision • Feb 19Consensus EPS estimates increase by 45%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from ₽488.8b to ₽527.6b. EPS estimate increased from ₽1,261 to ₽1,831 per share. Net income forecast to shrink 12% next year vs 14% growth forecast for Chemicals industry in Russian Federation . Consensus price target broadly unchanged at ₽5,597. Share price was steady at ₽5,870 over the past week.
Major Estimate Revision • Feb 17Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽416.5b to ₽477.2b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price was steady at ₽5,926 over the past week.
Reported Earnings • Feb 12Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: ₽1,002 (up from ₽131 in FY 2020). Revenue: ₽420.5b (up 66% from FY 2020). Net income: ₽129.7b (up ₽112.8b from FY 2020). Profit margin: 31% (up from 6.7% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) also surpassed analyst estimates by 6.2%. Over the next year, revenue is forecast to grow 3.2%, compared to a 15% growth forecast for the industry in Russia. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.
Major Estimate Revision • Feb 11Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₽409.3b to ₽473.3b. EPS estimate unchanged from ₽1,282 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 15% next year. Consensus price target reaffirmed at ₽5,475. Share price rose 13% to ₽5,936 over the past week.
Upcoming Dividend • Dec 10Upcoming dividend of ₽234 per shareEligible shareholders must have bought the stock before 17 December 2021. Payment date: 21 December 2021. Payout ratio is a comfortable 72% and this is well supported by cash flows. Trailing yield: 5.3%. Lower than top quartile of Russian dividend payers (8.2%). Higher than average of industry peers (4.0%).
Reported Earnings • Nov 12Third quarter 2021 earnings released: EPS ₽303 (vs ₽10.19 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₽116.3b (up 64% from 3Q 2020). Net income: ₽39.2b (up ₽40.5b from 3Q 2020). Profit margin: 34% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year whereas the company’s share price has increased by 32% per year.
Upcoming Dividend • Sep 16Upcoming dividend of ₽156 per shareEligible shareholders must have bought the stock before 23 September 2021. Payment date: 27 September 2021. Trailing yield: 5.9%. Lower than top quartile of Russian dividend payers (8.1%). Higher than average of industry peers (2.4%).
Reported Earnings • Aug 08Second quarter 2021 earnings released: EPS ₽234 (vs ₽161 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: ₽88.7b (up 48% from 2Q 2020). Net income: ₽30.3b (up 45% from 2Q 2020). Profit margin: 34% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.
Major Estimate Revision • Aug 07Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 revenue forecast increased from ₽325.4b to ₽393.0b. EPS estimate unchanged from ₽524 at last update. Chemicals industry in Russian Federation expected to see average net income growth of 17% next year. Consensus price target broadly unchanged at ₽4,045. Share price was steady at ₽4,573 over the past week.
Upcoming Dividend • Jun 25Upcoming dividend of ₽105 per shareEligible shareholders must have bought the stock before 02 July 2021. Payment date: 06 July 2021. Trailing yield: 6.2%. Lower than top quartile of Russian dividend payers (7.7%). Higher than average of industry peers (4.1%).
Upcoming Dividend • May 28Upcoming dividend of ₽63.00 per shareEligible shareholders must have bought the stock before 04 June 2021. Payment date: 08 June 2021. Trailing yield: 6.4%. Lower than top quartile of Russian dividend payers (8.0%). Higher than average of industry peers (4.3%).
Reported Earnings • May 21First quarter 2021 earnings released: EPS ₽142 (vs ₽120 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₽87.6b (up 37% from 1Q 2020). Net income: ₽18.4b (up ₽33.9b from 1Q 2020). Profit margin: 21% (up from net loss in 1Q 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Feb 20Full year 2020 earnings released: EPS ₽131 (vs ₽381 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ₽253.9b (up 2.3% from FY 2019). Net income: ₽16.9b (down 66% from FY 2019). Profit margin: 6.7% (down from 20% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
Analyst Estimate Surprise Post Earnings • Feb 20Revenue and earnings miss expectationsRevenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 11%. Over the next year, revenue is forecast to grow 13%, compared to a 3.2% growth forecast for the Chemicals industry in Russia.
Is New 90 Day High Low • Feb 15New 90-day high: ₽3,717The company is up 21% from its price of ₽3,084 on 17 November 2020. The Russian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽2,498 per share.
Major Estimate Revision • Feb 10Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ₽215 to ₽258. Revenue estimate for the same period was approximately flat at ₽260.9b. Net income is expected to grow by 356% next year compared to 25% growth forecast for the Chemicals industry in Russian Federation. The consensus price target was lowered from ₽50.69 to ₽47.62. Share price is down by 1.1% to ₽3,622 over the past week.
Major Estimate Revision • Nov 08Analysts update estimatesThe 2020 consensus earning per share (EPS) estimate increased from ₽226 to ₽249. Revenue estimate for the same period was approximately flat at ₽255.7b. Net income is expected to grow by 73% next year compared to 13% growth forecast for the Chemicals industry in Russian Federation. The consensus price target was lowered from ₽43.38 to ₽43.27. Share price is up 5.5% to ₽2,974 over the past week.
Is New 90 Day High Low • Nov 07New 90-day high: ₽2,974The company is up 11% from its price of ₽2,680 on 07 August 2020. The Russian market is down 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽3,489 per share.
Is New 90 Day High Low • Sep 28New 90-day high: ₽2,821The company is up 7.0% from its price of ₽2,643 on 30 June 2020. The Russian market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₽2,189 per share.